Stephenson’s Rocket was a major driver of the last industrial revolution two hundred years ago. Will the UK PM, Johnson, be able to deliver a similar principle that will be recognised in two hundred years from now?
Wilke Reints, Managing Director of Siemens Mobility Limited’s Intelligent Traffic Systems business, turns our thoughts towards intelligent traffic systems (ITS) including comment on traffic volumes, air quality and electric vehicles.
John Grimm, Vice President of Strategy and Business Development at Entrust, shares his advice on how health organisations can minimise the chances of a security breach at a time when resources are stretched more than ever.
Chief Scientist at Dynamic Object Language Labs Inc, Dr Paul Robertson explains how autonomous AI systems are key to achieving synergy between humans and robotics that can work together as a team.
Richard Cox, managing director of Langley Business Systems, gives an overview of the main ways hospitality businesses can maximise technology to navigate through the pandemic and ensure customers feel safe when visiting their premises.
Sal Murdoch, Marketing Director at Fiscal Technologies, discusses how AI can be used to simplify complexity and deliver clarity across public sector procure-to-pay.
Timothy Kwok, Professor at The Chinese University of Hong Kong, tells us about the Electronic Cognitive Screen (EC-Screen) that gives a brief and user-friendly digital cognitive test for the detection of dementia in older people.
Minister of Education, Culture, Sports, Science and Technology, HAGIUDA Koichi, explains the priorities for science, technology and innovation policy in Japan.
The rise of the virtual ward is charted here by Max Mckiernan, L2S2’s Marketing Manager and Jane Aldridge, Co-Founder/CBDO/CFO, including analysis of why COVID may save the NHS.
Here, we discover that SymlConnect digitises the paper-processes, offering remote monitoring to improve efficiency in care monitoring and reducing the waiting list exacerbated by the COVID-19 pandemic.
Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.
